# UNIVERSITY OF WISCONSIN-MADISON: Project 3: Extending Clinical Benefit by Selective Treatment of Resistant Lesions in mCRPC

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF WISCONSIN-MADISON |
| Location | MADISON, WI |
| Project | Project 3: Extending Clinical Benefit by Selective Treatment of Resistant Lesions in mCRPC |
| Project number | 5P50CA269011-04 |
| Mechanism | P50 |
| Institute | National Cancer Institute |
| Award | $364,483 |
| Awarded | 2026-09-17 |
| Project period | 2023-07-01 to 2028-06-30 |
| UEI | LCLSJAGTNZQ7 |

## Why this score
- Award of $364,483.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11398992). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.